A comprehensive understanding of the role of PKC-α during CSOM employing animal models will pave the way to design effective treatment modalities against the disease and prevent consequent hearing loss as well as life-threatening CNS disorders. This evidence concerns the gene PRKCA and central nervous system disorder.